Office of the Registrar or Lobbying of BC

Menus

  • Menus

www.lobbyistsregistrar.bc.ca

  • www.lobbyistsregistrar.bc.ca

Designated Filer menu

  • Registry Search Tools
    • 12-Month Lobbying Activity Search
    • Advanced Registry Search
  • Reporting Tools
    • Recent Registrations
    • Recent Lobbying Activity Reports by Posted Date
    • Government Funding Report
    • Gifts to Public Office Holders Report
    • Listing of All Lobbyists and Senior Officers
    • Listing of Senior Public Officer Holders who are in Lobbying Activity Reports
    • Listing of Organizations Clients and their Direct Interests
  • Lobbying Statistics
    • Active Lobbyists and Registrations by Type
    • Ministries/Provincial Entities in Active Registrations
    • Ministries/Provincial Entities in Lobbying Activity Reports
    • Lobbying Activity Reports by Reporting Period
    • Subject Matter in Active Registrations
    • Subject Matter in Lobbying Activity Reports
    • Intended Outcomes in Active Registrations
    • Intended Outcomes in Lobbying Activity Reports
  • Help
    • LTA Guidance Documents
    • Using the Registry
    • Legislation
    • LTA Frequently Asked Questions
    • Contact Us
  • Sign In

You are here:

  1. Registry Dashboard

 

Subject matter details

AbbVie Corporation


Registration: 10 of 22 (2024-04-05 to 2024-05-08)

Details Regarding the Identified Subject Matter
Specific Topics of Lobbying Communications Intended Outcomes Associated Subject Matters
Advocate for health policy evaluation regarding the measurement of the value of public expenditures on medications with respect to patient outcomes, healthcare system sustainability and appropriation of funding for medications.
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
Health, Science and Technology
Gain and maintain reimbursement of AbbVie biopharmaceutical products as per provincial reviews and as defined by Pharmacare, BC Cancer Agency, BC Centre for Excellence in HIV and AIDS, and Regional Health Authorities; emphasize the roles, value and outcomes of AbbVie biopharmaceutical products in providing benefits to patient health and contribution to the BC healthcare system.
Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity
Health, Hospitals
Policy and program recommendations regarding creation of a robust BC life sciences eco-system that will lead to increased research and development activities in BC.
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
Health, Science and Technology